Abstract
Introduction:Hemangiomas arise from the proliferation of endothelial cells surrounding blood-filled cavities. They have a slightly higher female predilection and about 60–70% of them occur in the head and neck region. Various medical and surgical options are available for the treatment of hemangiomas.Aim: To determine the pattern and management outcomes of head and neck hemangiomas in Tanzania.Material and methods: This was a one-year prospective, cross-sectional study that involved all consecutive patients with head and neck hemangiomas treated in Muhimbili National Hospital. A structured questionnaire was used to collect information including age and sex of the patient, chief complaint and, duration, size and site of the lesion. The treatment modalities were surgery and/or intralesional bleomycin injection (IL-Bleo). A standard dose of bleomycin was 0.3 to 0.6 mg/kg per injection not exceeding 15 units per cycle with a maximum of 6 cycles. Frequency distribution and cross-tabulation were performed and association between variables was assessed by the Chi-square test, whereby thep-value was set atp< 0.05.Results:A total of 58 patients were included in the study. The male to female ratio was 1:1.4 and the median age was 6.15 years. Majority (74%) of the patients had infantile hemangioma. The most common presenting complaint of patients/guardians of the patients were facial disfigurement (94.8%), pain (32.8%) and ulceration (22.4%). The most frequently involved sites were the lips (55.2%) followed by the cheeks (37.9%). In patient who were managed surgically, there was a 100% reduction in size of the lesion. Of those who were treated with bleomycin, the percentage reduction in the area of the lesion ranged from 8.33% to 100% with mean of 72.6%. Only 6% of the patient had post IL-Bleo complications.Conclusion:Head and Neck hemangiomas are more common in females and majority are infantile hemangioma. Facial disfigurement is the commonest presenting complication of these lesions, and the lips and the cheeks are mostly affected areas. Intralesional bleomycin is an effective treatment modality which has low complication rates.
Highlights
Hemangiomas arise from the proliferation of endothelial cells surrounding blood-filled cavities [1]
This was a one-year prospective, cross-sectional study that involved all consecutive patients with head and neck hemangiomas treated at the oral and maxillofacial department of the Muhimbili National Hospital (MNH) between March 2018 and February 2019
The inclusion criteria were all patients with head and neck hemangiomas who had never been treated for their condition before presenting to us
Summary
Hemangiomas arise from the proliferation of endothelial cells surrounding blood-filled cavities [1]. They constitute 7% of all benign tumors with about 60–70% of hemangiomas found in the head and neck region [2,3]. These lesions have slightly higher female predilection [4]. Hemangiomas are broadly classified as infantile or congenital hemangiomas. The infantile hemangiomas (IH) are either absent or present as a precursor lesion at birth [5] while the congenital hemangiomas (CH) occur fully grown at birth [2]. Congenital hemangiomas can either involute rapidly over a very brief period in infancy (rapidly involuting congenital hemangioma (RICH)) or never involute (non-involuting congenital hemangioma (NICH)) [6]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.